Alpha Tau Medical Warrant
DRTSW
42 hedge funds and large institutions have $3.94M invested in Alpha Tau Medical Warrant in 2022 Q1 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCP
Corbin Capital Partners
New York
|
+$304K |
| 2 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
+$244K |
| 3 |
QGA
Q Global Advisors
Fort Worth,
Texas
|
+$164K |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$123K |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$120K |
Top Sellers
DRTSW Hedge Fund Activity: Q1 2022 in Review
42 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical Warrant (DRTSW) for Q1 2022, worth a combined $3.94M.
Buyers outnumbered sellers: 42 funds opened new DRTSW positions and 0 closed out — a net gain of 42 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Corbin Capital Partners, opening a new position worth an estimated $304K.
- 42 institutional investors held Alpha Tau Medical Warrant (DRTSW) as of Q1 2022, up from 0 in Q4 2021.
- Funds reported $3.94M of Alpha Tau Medical Warrant stock for Q1 2022.
- 42 funds opened new Alpha Tau Medical Warrant positions in Q1 2022 and 0 closed out, a net change of +42 holders.
- The largest Alpha Tau Medical Warrant buyer in Q1 2022 was Corbin Capital Partners, an estimated $304K added.
Based on aggregated 13F filings for Q1 2022.